Matthew Pianko, MD

Congratulations to the @Regeneron team. Disappointed we cannot use earlier in the course of the disease. Would gladly use for first relapse in many patients with advanced age. Attrition erodes success.

🩸 Hem/Onc physicians, including community practitioners, fellows & faculty — join us for the Fall 2025 Hematologic Malignancies Symposium at @UMichMedicine! 📅 Sat, Oct 11 | ⏰ 9 AM–3:30 PM 📍 The Kensington Hotel, Ann Arbor, MI 💵 No cost to attend 💡 Focus on myeloma,…

Many oncologists dismiss nutrition as part of a patients overall cancer care plan since they don’t get nutrition training. I discuss nutrition in oncology with Dr Tracy Cushing and Dr Eden English on their podcast. Hope this episode changes your mind. tinyurl.com/y373sz9u 1/3

Calling all physicians/advanced practice providers seeing pts with multiple myeloma! We invite you to participate in a quick survey on "Clinician Perspectives on Smoldering Myeloma." Led by @bdermanmd @rajshekharucms @Eddie_Cliff Survey link: bit.ly/smolderingMM #mmsm

Our comprehensive review on dietary and microbiome evidence in plasma cell disorders @richaparikh36 @LesokhinMD Francesca Castro and Matteo Bellone @MSK_DeptOfMed @LeukemiaJnl #mmsm #microbiome #nutrition #diet rdcu.be/c8JFV

waiting patiently for @BCBSM to approve Teclistamab for my patient in great need of this drug. Apparently ‘urgent’ means a 10-14 day review time. Unreasonable prior authorization times are dangerous and irresponsible. What can be done to stop this madness? #mmsm

EMERSE was instrumental to this project evaluating PJP risk and use of PJP prophylaxis in autoHSCT recipients at UM 2001-2019. Thanks @informaticsGeek for creating this great resource for clinical research. @UMIntMed @BMTjournal

Congratulations @mpianko @HassounHani Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease Emphasizing the need for a consensus approach onlinelibrary.wiley.com/doi/10.1002/aj… #mmsm @MSKCancerCenter @AjHematology @szusmani @MSKHemOncTrials @MSK_DeptOfMed

#ASH22 @HiraSMian from @McMasterU presents an interim analysis and data from the prospective MFRAIL clinical study, evaluating the association of frailty assessments at at baseline and longitudinally with clinical outcomes in patients with MM #mmsm #MYELOMA

@myCARG is pleased to announce its 2022 Pilot Grant Awardees. Congratulations to Drs. @freemanlciaraMD and @mpianko! More info here: mycarg.org/?page_id=172

Great times at the ASH Foundation 5K with the current and former UM fellows! @chrissu @weissdoc1 Lisa Chu, and Sam Reynolds #humidity #ash22

master presenter Ajai Chari presenting Talquetamab a bispecific antibody targeting GPRC5D. Amazing 74% ORR and even more remarkable low infection rates grade 3/4 at 17% and 12%. This is remarkable and may likely be the next bispecific and First GPRC5D available #ASH22 #MedIQ22ASH

Congratulations to our next incoming class of Hematology/Oncology fellows, we look forward to working with you! @Nate_WilsonMD @XiYangupmc1 @ShihanNKhan @SSRehmani Gong He, Prarthana @maitkencancerhx Dalal @UMHemOncFellows @UMIntMed @UMRogelCancer

Thanks @corywong for spending 5,019 minutes with me in 2022. I couldn’t stop listening to First Avenue. Your productivity is ridiculously impressive. Looking forward to your Detroit show! #SpotifyWrapped open.spotify.com/artist/6xt9sJm…